Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.75
-0.10 (-0.53%)
At close: Apr 27, 2026
22.55%
Market Cap 15.23B
Revenue (ttm) 1.90B
Net Income (ttm) 337.87M
Shares Out 810.02M
EPS (ttm) 0.51
PE Ratio 37.13
Forward PE 26.59
Dividend 0.70 (3.73%)
Ex-Dividend Date Nov 24, 2025
Volume 2,353,742
Average Volume 4,412,108
Open 18.85
Previous Close 18.85
Day's Range 18.40 - 19.10
52-Week Range 14.95 - 40.10
Beta n/a
RSI 37.28
Earnings Date May 8, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd. [Read more]

Industry Packaged Foods
Founded 2018
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements

News

There is no news available yet.